Kingâs Daughters Health System in Ashland, seen on Friday, and UK HealthCare, the clinical health care system of the University of Kentucky, announced Friday their intent to enter into a significant partnership to better serve patients in the Tri-State region.Â
Sholten Singer | The Herald-Dispatch
King’s Daughters Health System (KDHS) is comprised of two acute-care facilities – 465 licensed beds in Ashland and an additional 10 licensed beds at King’s Daughters Medical Center Ohio in Portsmouth.
ASHLAND, Ky. (Jan. 29, 2021) King’s Daughters Health System and UK HealthCare, the clinical health care system of the University of Kentucky, announced today their intent to enter into a significant partnership that will create new opportunities for both organizations to better serve patients throughout Kentucky, southern Ohio and West Virginia.
The executive committee of UK’s Board of Trustees and King’s Daughters Board of Directors endorsed the formation of the new joint venture partnership during special meetings this morning. It is anticipated that the final operational details of the partnership will be announced in early April.
Markey joined a coalition of 76 cancer centers and national organizations to encourage Americans to stay on track with cancer screenings and treatment during the pandemic.
LEXINGTON, Ky. (Jan. 29, 2021) The University of Kentucky Markey Cancer Center is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
The coalition of 76 organizations has released an open letter reminding the public that cancer still poses a major threat to people’s health, but acting as soon as is safely possible can lead to much better outcomes in the future. The letter examines distressing trends showing a significant drop-off in recommended cancer screening and treatment compared to prior years. This concerning side-effect of the pandemic could lead to a staggering number of preventable cancer death
of
LEXINGTON, Ky. (Jan. 28, 2021) UK HealthCare, home to the University of Kentucky Markey Cancer Center, has officially been recognized as a System of Excellence for Hidden Scar breast cancer surgery, the highest level of Hidden Scar designation. UK HealthCare is the first and only hospital system in Kentucky to be certified as a Hidden Scar System of Excellence. This surgical option provides the women of Kentucky with a procedure that effectively treats breast cancer while optimizing cosmetic results.
The American Cancer Society estimates that 3,800 Kentucky women will be diagnosed with breast cancer this year. Of those women, most will need surgery as part of their treatment. Though surgical techniques over the decades have improved, traditional breast cancer surgeries still leave visible scars behind.
A new study by Markey researchers shows a higher-than-average rate of DACH1 mutations in Kentucky patients with endometrial cancer.
LEXINGTON, Ky. (Jan. 12, 2020) A new study by University of Kentucky Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.
DACH1 is a transcriptional repressor and tumor suppressor gene that is frequently mutated in other cancers, including melanoma, bladder and prostate cancer. The loss of DACH1 expression is also associated with poor prognosis and reduced survival in women with uterine cancer.
Published in PLOS One, the study sought to determine the frequency of DACH1 mutations in patients with endometrial cancer in Kentucky. Using the Oncology Research Information Exchange Network (ORIEN), a personalized medicine consortium that Markey joined in 2017, researchers examined clinical and genomic